Skip to main content

TILT Biotherapeutics

Helsinki, Finland

TILT Biotherapeutics Ltd is the leading company globally working in the area of enabling tumor.

$25.3M raised
May 2025
Series B

Top Investors

Lifeline VenturesTesiBusiness FinlandEuropean Innovation CouncilU.S. Department of Defense

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about TILT Biotherapeutics

How much funding has TILT Biotherapeutics raised?
TILT Biotherapeutics has raised $25.3M in total funding. The most recent round was Series B. The last funding was announced in May 2025.
Who are TILT Biotherapeutics's investors?
TILT Biotherapeutics's investors include Lifeline Ventures, Tesi, Business Finland, European Innovation Council, U.S. Department of Defense.
Where is TILT Biotherapeutics headquartered?
TILT Biotherapeutics is headquartered in Helsinki, Finland.
What does TILT Biotherapeutics do?
TILT Biotherapeutics Ltd is the leading company globally working in the area of enabling tumor.
What stage is TILT Biotherapeutics at?
TILT Biotherapeutics is at the Series B stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"TILT Biotherapeutics — Funding & Investors." VCBacked, May 13, 2025, https://www.vcbacked.co/company/tilt-biotherapeutics. Accessed June 4, 2026.
APA
VCBacked. (2025). TILT Biotherapeutics — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/tilt-biotherapeutics
Wikipedia (cite web)
{{cite web |title=TILT Biotherapeutics — Funding & Investors |url=https://www.vcbacked.co/company/tilt-biotherapeutics |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .